Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study on the Efficacy and Safety of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease.

NCT06879782 is registered in ClinicalTrials.gov with Lunan Better Pharmaceutical Co., LTD. as lead sponsor.

NCT NCT06879782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06879782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study on the Efficacy and Safety of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease.
Lead sponsor
Lunan Better Pharmaceutical Co., LTD.
Phase
Phase 3
Overall status
Recruiting
Start date
March 28, 2024
Completion date
September 28, 2026
Enrollment
820 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)